Eosinophils and primary biliary cirrhosis—Stoking the fire?
Open Access
- 1 July 1999
- journal article
- editorial
- Published by Wolters Kluwer Health in Hepatology
- Vol. 30 (1) , 335-337
- https://doi.org/10.1002/hep.510300150
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosisHepatology, 1999
- Expression of pyruvate-dehydrogenase complex PDC-E2 on biliary epithelial cells induced by lymph nodes from primary biliary cirrhosisThe Lancet, 1998
- Cytokines in Primary Biliary CirrhosisSeminars in Liver Disease, 1997
- Elevations in IFN-γ, IL-5, and IL-10 in Patients with the Autoimmune Disease Primary Biliary Cirrhosis: Association with Autoantibodies and Soluble CD30Clinical Immunology and Immunopathology, 1996
- Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosisDigestive Diseases and Sciences, 1996
- Differential effects of chenodeoxycholic and ursodeoxycholic acids on expression of procoagulant activity by human monocytesJournal of Hepatology, 1994
- Eosinophilic infiltration of the liver in primary biliary cirrhosis: A morphological studyHepatology, 1993
- Immunomodulatory Effects of Ursodeoxycholic Acid on Immune ResponsesHepatology, 1992
- A controlled trial of prednisolone treatment in primary biliary cirrhosisJournal of Hepatology, 1992
- The eosinophil and bronchial asthma: Current understandingJournal of Allergy and Clinical Immunology, 1990